Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


11.02.2019

2 Ann Oncol
2 Ann Thorac Surg
5 Anticancer Res
2 Arch Pathol Lab Med
1 BMC Cancer
2 Br J Cancer
1 Cancer Epidemiol Biomarkers Prev
3 Cancer Lett
3 Cancer Res
2 Clin Lung Cancer
1 Clin Nucl Med
1 Epidemiology
2 Eur J Cardiothorac Surg
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
2 J Thorac Cardiovasc Surg
4 J Thorac Oncol
1 Lancet Oncol
4 Lung Cancer
1 Mol Carcinog
5 Oncol Rep
5 PLoS One
1 Proc Natl Acad Sci U S A
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. PLANCHARD D, Popat S, Kerr K, Novello S, et al
    Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2019 Jan 30. pii: 5304567. doi: 10.1093.
    PubMed     Text format    

  2. MORABITO A
    Improving our knowledge in PD-L1 testing in lung cancer: the archival sample is 'promoted'!
    Ann Oncol. 2019 Feb 2. pii: 5306111. doi: 10.1093.
    PubMed     Text format    


    Ann Thorac Surg

  3. VERDIAL F, Madtes D, Hwang B, Mulligan M, et al
    A Prediction Model for Nodal Disease among Patients with Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2019 Jan 30. pii: S0003-4975(19)30111.
    PubMed     Text format     Abstract available

  4. BRESCIA AA, Harrington CA, Waljee JF, Lagisetty KH, et al
    Predictors of Opioid Prescription After Early Stage Lung Cancer Surgery (Reply).
    Ann Thorac Surg. 2019 Jan 29. pii: S0003-4975(19)30122.
    PubMed     Text format    


    Anticancer Res

  5. PARIKH AB, Hammons L, Gomez JE
    Neoadjuvant Tyrosine Kinase Inhibition in Locally-advanced Non-small Cell Lung Cancer: Two Cases and a Brief Literature Review.
    Anticancer Res. 2019;39:897-902.
    PubMed     Text format     Abstract available

  6. KATSURADA M, Nagano T, Tachihara M, Kiriu T, et al
    Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer.
    Anticancer Res. 2019;39:815-825.
    PubMed     Text format     Abstract available

  7. SARUWATARI K, Ikeda T, Saeki S, Shingu N, et al
    Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases.
    Anticancer Res. 2019;39:923-931.
    PubMed     Text format     Abstract available

  8. AKSORN N, Chanvorachote P
    Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer.
    Anticancer Res. 2019;39:541-548.
    PubMed     Text format     Abstract available

  9. KUBO N, Harada T, Shiraishi Y, Nosaki K, et al
    Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer.
    Anticancer Res. 2019;39:671-677.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  10. GUERINI-ROCCO E, Passaro A, Casadio C, De Luca VM, et al
    Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers: The Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples.
    Arch Pathol Lab Med. 2018;142:465-473.
    PubMed     Text format     Abstract available

  11. ALI G, Bruno R, Savino M, Giannini R, et al
    Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?
    Arch Pathol Lab Med. 2018;142:480-489.
    PubMed     Text format     Abstract available


    BMC Cancer

  12. ZACHARIAS M, Brcic L, Eidenhammer S, Popper H, et al
    Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulated.
    BMC Cancer. 2018;18:717.
    PubMed     Text format     Abstract available


    Br J Cancer

  13. DI GIROLAMO C, Walters S, Gildea C, Benitez Majano S, et al
    Which patients are not included in the English Cancer Waiting Times monitoring dataset, 2009-2013? Implications for use of the data in research.
    Br J Cancer. 2018;118:733-737.
    PubMed     Text format     Abstract available

  14. GHOSH KM, Lee LH, Beckingsale TB, Gerrand CH, et al
    Indeterminate nodules in osteosarcoma: what's the follow-up?
    Br J Cancer. 2018;118:634-638.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  15. PETERS BA, Hayes RB, Goparaju C, Reid C, et al
    The microbiome in lung cancer tissue and recurrence-free survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0966.
    PubMed     Text format     Abstract available


    Cancer Lett

  16. RUANO-RAVINA A, Rodriguez-Martinez A, Torres-Duran M, Barros-Dios JM, et al
    Reply: Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30056.
    PubMed     Text format    

  17. BEVELACQUA JJ, Dobrzynski L, Welsh J, Mortazavi SMJ, et al
    Commentary regarding "Residential radon and small cell lung cancer. A systematic review".
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30050.
    PubMed     Text format     Abstract available

  18. YAN C, Luo L, Urata Y, Goto S, et al
    Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment.
    Cancer Lett. 2018;418:204-210.
    PubMed     Text format     Abstract available


    Cancer Res

  19. LI YP, Sin TK, Zhu JZ, Zhang G, et al
    p300 mediates muscle wasting in Lewis lung carcinoma.
    Cancer Res. 2019 Jan 31. pii: 0008-5472.CAN-18-1653.
    PubMed     Text format     Abstract available

  20. MURTUZA A, Bulbul A, Shen JP, Keshavarzian P, et al
    Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-1281.
    PubMed     Text format     Abstract available

  21. YAN Y, Sun N, Wang H, Kobayashi M, et al
    Whole genome-derived tiled peptide arrays detect pre-diagnostic autoantibody signatures in non-small cell lung cancer.
    Cancer Res. 2019 Feb 5. pii: 0008-5472.CAN-18-1536.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  22. NOKIHARA H, Nishio M, Yamamoto N, Fujiwara Y, et al
    Phase 1 Study of Cabozantinib in Japanese Patients With Expansion Cohorts in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2018 Dec 31. pii: S1525-7304(18)30355.
    PubMed     Text format     Abstract available

  23. CERRA-FRANCO A, Liu S, Azar M, Shiue K, et al
    Predictors of Nodal and Metastatic Failure in Early Stage Non-small-cell Lung Cancer After Stereotactic Body Radiation Therapy.
    Clin Lung Cancer. 2018 Dec 29. pii: S1525-7304(18)30353.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  24. SU TP, Ho KC, Wang CW, Lin CY, et al
    Prognostic Value and Clinical Impact of Pretreatment FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma.
    Clin Nucl Med. 2019;44:e68-e75.
    PubMed     Text format     Abstract available


    Epidemiology

  25. RICE MB, Li W, Dorans KS, Wilker EH, et al
    Exposure to Traffic Emissions and Fine Particulate Matter and Computed Tomography Measures of the Lung and Airways.
    Epidemiology. 2018;29:333-341.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  26. BATIREL HF
    Solid to ground-glass opacity ratio in lung adenocarcinomas: is it a new criterion for limited pulmonary resection?
    Eur J Cardiothorac Surg. 2018 Mar 8. pii: 4924815. doi: 10.1093.
    PubMed     Text format    

  27. LI H, Sun Z, Yang F, Sui X, et al
    Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.
    Eur J Cardiothorac Surg. 2019 Feb 4. pii: 5306618. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  28. ZHANG B, Wu Q
    Erratum: The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer.
    Int J Cancer. 2019;144:E2.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  29. HURMUZ P, Cengiz M, Zorlu F, Akyol F, et al
    In Regard to Kumar et al.
    Int J Radiat Oncol Biol Phys. 2018;100:1079-1080.
    PubMed     Text format    

  30. LOURENCO LM, Jiang Y, Drobnitzky N, Green M, et al
    PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice.
    Int J Radiat Oncol Biol Phys. 2018;100:767-775.
    PubMed     Text format     Abstract available

  31. TEKATLI H, Duijm M, Oomen-de Hoop E, Verbakel W, et al
    Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2018;100:738-747.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  32. HSIN MK, Ho JC
    It is not as bad as they say: The risks of surgery in screening-detected lung cancer are overstated.
    J Thorac Cardiovasc Surg. 2018 Dec 25. pii: S0022-5223(18)33482.
    PubMed     Text format    

  33. BOTT MJ, Yang SC, Park BJ, Adusumilli PS, et al
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 13. pii: S0022-5223(18)33277.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  34. EL OSTA B, Behera M, Kim S, Berry LD, et al
    Characteristics and outcomes of patients with metastatic KRAS mutant lung adenocarcinomas: The Lung Cancer Mutation Consortium experience.
    J Thorac Oncol. 2019 Feb 5. pii: S1556-0864(19)30097.
    PubMed     Text format     Abstract available

  35. ZHAO X, Kallakury B, Chahine JJ, Hartmann D, et al
    Surgical resection of small cell lung carcinoma: prognostic factors and the tumor microenvironment.
    J Thorac Oncol. 2019 Feb 5. pii: S1556-0864(19)30096.
    PubMed     Text format     Abstract available

  36. IJSSELDIJK MA, Shoni M, Siegert C, Wiering BM, et al
    Survival after SBRT for Clinically diagnosed or Biopsy-proven Early-stage Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    J Thorac Oncol. 2019 Feb 2. pii: S1556-0864(19)30094.
    PubMed     Text format     Abstract available

  37. KIM ES, Roy UB, Ersek JL, King J, et al
    Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.
    J Thorac Oncol. 2019 Jan 29. pii: S1556-0864(19)30003.
    PubMed     Text format    


    Lancet Oncol

  38. ILEANA-DUMBRAVA E, Subbiah V
    Autoimmune hypophysitis.
    Lancet Oncol. 2018;19:e123.
    PubMed     Text format    


    Lung Cancer

  39. QIN BD, Jiao XD, Zang YS
    Primary pulmonary leiomyosarcoma: A population-based study.
    Lung Cancer. 2018;116:67-72.
    PubMed     Text format     Abstract available

  40. PAAJANEN J, Laaksonen S, Ilonen I, Wolff H, et al
    Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
    Lung Cancer. 2018;116:73-79.
    PubMed     Text format     Abstract available

  41. ZHOU F, Hou L, Ding T, Song Q, et al
    Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
    Lung Cancer. 2018;116:30-37.
    PubMed     Text format     Abstract available

  42. TAKADA K, Toyokawa G, Tagawa T, Kohashi K, et al
    PD-L1 expression according to the EGFR status in primary lung adenocarcinoma.
    Lung Cancer. 2018;116:1-6.
    PubMed     Text format     Abstract available


    Mol Carcinog

  43. SUMARDIKA IW, Chen Y, Tomonobu N, Kinoshita R, et al
    NEUROPLASTIN-beta MEDIATES S100A8/A9-INDUCED LUNG CANCER DISSEMINATIVE PROGRESSION.
    Mol Carcinog. 2019 Feb 5. doi: 10.1002/mc.22987.
    PubMed     Text format     Abstract available


    Oncol Rep

  44. ZOU M, Hu X, Xu B, Tong T, et al
    Glutathione Stransferase isozyme alpha 1 is predominantly involved in the cisplatin resistance of common types of solid cancer.
    Oncol Rep. 2019;41:989-998.
    PubMed     Text format     Abstract available

  45. DUAN Y, Liu T, Li S, Huang M, et al
    CHAF1B promotes proliferation and reduces apoptosis in 95D lung cancer cells and predicts a poor prognosis in nonsmall cell lung cancer.
    Oncol Rep. 2019 Feb 1. doi: 10.3892/or.2019.6994.
    PubMed     Text format     Abstract available

  46. FU Q, Huang Y, Ge C, Li Z, et al
    SHIP1 inhibits cell growth, migration, and invasion in nonsmall cell lung cancer through the PI3K/AKT pathway.
    Oncol Rep. 2019 Jan 30. doi: 10.3892/or.2019.6990.
    PubMed     Text format     Abstract available

  47. ZHANG N, Jiang W
    Long noncoding RNA DANCR promotes HMGA2mediated invasion in lung adenocarcinoma cells.
    Oncol Rep. 2019;41:1083-1090.
    PubMed     Text format     Abstract available

  48. YONESAKA K, Kobayashi Y, Hayashi H, Chiba Y, et al
    Dual blockade of EGFR tyrosine kinase using osimertinib and afatinib eradicates EGFRmutant Ba/F3 cells.
    Oncol Rep. 2019;41:1059-1066.
    PubMed     Text format     Abstract available


    PLoS One

  49. FUKUOKA M, Yoshioka K, Hohjoh H
    NF-kappaB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells.
    PLoS One. 2018;13:e0201796.
    PubMed     Text format     Abstract available

  50. RATH EM, Cheng YY, Pinese M, Sarun KH, et al
    BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state.
    PLoS One. 2018;13:e0203003.
    PubMed     Text format     Abstract available

  51. PADAYACHEE T, Khamiakova T, Louis E, Adriaensens P, et al
    The impact of the method of extracting metabolic signal from 1H-NMR data on the classification of samples: A case study of binning and BATMAN in lung cancer.
    PLoS One. 2019;14:e0211854.
    PubMed     Text format     Abstract available

  52. KEMP JACOBSEN K, Johansen JS, Mellemgaard A, Bojesen SE, et al
    AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival.
    PLoS One. 2019;14:e0211745.
    PubMed     Text format     Abstract available

  53. CHO YJ, Kim WS, Choi YH, Ha JY, et al
    Computerized texture analysis of pulmonary nodules in pediatric patients with osteosarcoma: Differentiation of pulmonary metastases from non-metastatic nodules.
    PLoS One. 2019;14:e0211969.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  54. CHEN S, Giannakou A, Wyman S, Gruzas J, et al
    Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Proc Natl Acad Sci U S A. 2018;115:E11671-E11680.
    PubMed     Text format     Abstract available


    Thorax

  55. YONG PC, Sigel K, de-Torres JP, Mhango G, et al
    The effect of radiographic emphysema in assessing lung cancer risk.
    Thorax. 2019 Feb 5. pii: thoraxjnl-2018-212457.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: